The effect of wet-cupping on amenorrhea and oligomenorrhea

Evaluation the efficacy of calves wet cupping on vaginal bleeding induce in women with amenorrhea and oligomenorrhea.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016062728664N1

Enrollment

Registered

2016-08-04

Start date

2016-05-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Pcos. Condition 2: Ovarian dysfunction. Polycystic ovarian syndrome Ovarian dysfunction, unspecified

Interventions

Calves wet-cupping will done at the 26th day of menstruation cycle. When the patient is in the prone position, calf muscle is suctioned repeatedly to provide a negative pressure. Then under aseptic co

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 20-40 years old women with minimum 60 days menstruation retardation (from LMP); personal satisfaction; Not metformin or hormonal drugs users. Exclusion criteria: Use of hormonal or herbal drugs that affect menstruation; Positive BhcG; Lactation; Plannig to be pregnant during the next 3 months; History of thyroid dysfunction; History of anemia; History of coagulation diseases; History of diabetes mellitus; FSH >40; Hyperprolactinemia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Menstrual blood volume. Timepoint: Before intervention and 1, 2, 4 and 12 weeks after intervention. Method of measurement: Ask the patient and complete tracking form.;Occurance of Menstrual bleeding. Timepoint: Before intervention and 1, 2, 4 and 12 weeks after intervention. Method of measurement: Ask the patient.;Duration of menstural bleeding. Timepoint: Before intervention and 1, 2, 4 and 12 weeks after intervention. Method of measurement: Ask the patient and complete tracking form.	—

Measure

Time frame

Menstrual blood volume. Timepoint: Before intervention and 1, 2, 4 and 12 weeks after intervention. Method of measurement: Ask the patient and complete tracking form.;Occurance of Menstrual bleeding. Timepoint: Before intervention and 1, 2, 4 and 12 weeks after intervention. Method of measurement: Ask the patient.;Duration of menstural bleeding. Timepoint: Before intervention and 1, 2, 4 and 12 weeks after intervention. Method of measurement: Ask the patient and complete tracking form.

—

Secondary

Measure	Time frame
SHBG. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: SHBG serum assay.;Testosteron. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Serum testosteron assay.;Insulin resistance. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Fasting blood suger &insulin assay.;Quality of life. Timepoint: Before intervention and 4&12 weeks after intervention. Method of measurement: Ask the patient and complete tracking form.	—

Measure

Time frame

SHBG. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: SHBG serum assay.;Testosteron. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Serum testosteron assay.;Insulin resistance. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Fasting blood suger &insulin assay.;Quality of life. Timepoint: Before intervention and 4&12 weeks after intervention. Method of measurement: Ask the patient and complete tracking form.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzam Meyari

Traditional school of Shahid Beheshti University of Medical Sciences

d_a_meyari@yahoo.com; ameyari@sbmu.ac.ir+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026